
Immune checkpoint inhibitors combined with chemotherapy show significant benefits in patients with BRAF-mutant NSCLC, especially in first-line treatment.


coremsg

Various immune checkpoint inhibitors are used in the treatment of non-small cell lung cancer, but how effective are they in patients with BRAF mutations?

Immune Checkpoint Inhibitor Efficacy in BRAF-Mutant NSCLC

efficacy-of-immune-checkpoint-inhibitors-in-braf-mutant-nsclc


Efficacy of Immune Checkpoint Inhibitors in BRAF-Mutant NSCLC
